Type 2 & other diabetes

Associations of dietary magnesium intake with the risk of atherosclerotic cardiovascular disease and mortality in individuals with and without type 2 diabetes: A prospective study in the UK Biobank

Diabetes MetabPublished Prospective cohort study

Authors' conclusion

Sufficient dietary Mg intake was significantly associated with lower risks of ASCVD events and mortality in individuals with type 2 diabetes but not in those without type 2 diabetes. Our findings provide insight into the importance of dietary Mg intake for reducing modifiable cardiovascular burden in individuals with type 2 diabetes, which may inform future personalized dietary guidelines.

Study context

Population
UK Biobank participants with and without T2D4,603 with T2D
Participants
149,929 participants
Exposure
Sufficient dietary magnesium (Mg) intake (≥ recommended daily intake) vs insufficient, in individuals with and without T2D
Outcome
Incident ASCVD events and mortality (ASCVD and all-cause)
Follow-up
Median 12.0 and 12.1 years
Methodological detailsUK Biobank, Cox proportional hazard models, interaction on multiplicative and additive scales
  • UK Biobank
  • Cox proportional hazard models
  • Interaction on multiplicative and additive scales

Main finding

As reported in the abstract

ASCVD incidence, ASCVD mortality and all-cause mortality by T2D status
Sufficient Mg intake vs Insufficient Mg intakeHazard ratio (95 % CI)
ASCVD incidence, T2D
0.63(0.49–0.82)
ASCVD mortality, T2D
0.45(0.24–0.87)
All-cause mortality, T2D
0.71(0.52–0.97)
ASCVD incidence, without T2D
1.01(0.94–1.09)
ASCVD mortality, without T2D
1.25(0.93–1.66)
All-cause mortality, without T2D
0.97(0.88–1.07)
Incident atherosclerotic cardiovascular disease (ASCVD) events
7811
Deaths (including 599 ASCVD deaths)
5000

Observational data: associations, not effects.

Original publication

Associations of dietary magnesium intake with the risk of atherosclerotic cardiovascular disease and mortality in individuals with and without type 2 diabetes: A prospective study in the UK Biobank. Diabetes Metab. Published 29 June 2024. doi:10.1016/j.diabet.2024.101554

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.